Hunter Perkins Capital Management, LLC Voyager Therapeutics, Inc. Transaction History
Hunter Perkins Capital Management, LLC
- $451 Million
- Q3 2025
A detailed history of Hunter Perkins Capital Management, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 53,840 shares of VYGR stock, worth $215,360. This represents 0.06% of its overall portfolio holdings.
Number of Shares
53,840
Previous 60,340
10.77%
Holding current value
$215,360
Previous $188,000
33.51%
% of portfolio
0.06%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding VYGR
# of Institutions
125Shares Held
29.9MCall Options Held
121KPut Options Held
16.2K-
Black Rock Inc. New York, NY5.31MShares$21.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.2MShares$16.8 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.25MShares$13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.29MShares$9.17 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.48MShares$5.9 Million0.31% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $155M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...